Listeria monocytogenes meningitis in adults: the Czech Republic experience
Language English Country United States Media print-electronic
Document type Journal Article
PubMed
24106719
PubMed Central
PMC3784069
DOI
10.1155/2013/846186
Knihovny.cz E-resources
- MeSH
- Ampicillin administration & dosage MeSH
- Adult MeSH
- Fever MeSH
- Middle Aged MeSH
- Humans MeSH
- Listeria monocytogenes drug effects pathogenicity MeSH
- Meningitis, Bacterial cerebrospinal fluid drug therapy epidemiology microbiology MeSH
- Risk Factors MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Czech Republic epidemiology MeSH
- Names of Substances
- Ampicillin MeSH
BACKGROUND: Listeria monocytogenes (LM) is currently the third most frequent pathogen of bacterial meningitis in adults. METHODS: A prospective study of patients with LM meningitis in a Czech tertiary care hospital, carried out from 1997 to 2012. RESULTS: Thirty-one patients were diagnosed with LM meningitis, which was 7% of a total of 440 adult patients with acute bacterial meningitis (ABM) over a 16-year period. Their median age was 63 years, range 26-80 years. Nineteen patients (61%) had underlying immunocompromising comorbidity; 15 patients (48%) were older than 65 years. Fourteen patients (45%) had arterial hypertension. The typical triad of fever, neck stiffness, and altered mental status was present in 21 patients (68%). The median count of cerebrospinal fluid (CSF) leukocytes was 680/μL, protein level 2.6 g/L, and glucose ratio 0.28. Four patients (13%) died, and nine (29%) survived with moderate to severe sequelae. CONCLUSION: LM meningitis is known to affect immunosuppressed and elderly patients. Arterial hypertension seems to be another important predisposing factor. Clinical symptoms, CSF findings, and disease outcomes, did not significantly differ from other community-acquired ABM in our study, although the CSF leukocyte count was lower. Ampicillin showed good clinical and bacteriological efficacy in the majority of patients.
See more in PubMed
Amaya-Villar R, García-Cabrera E, Sulleiro-Igual E, et al. Three-year multicenter surveillance of community-acquired Listeria monocytogenes meningitis in adults. BMC Infectious Diseases. 2010;10, article 324 PubMed PMC
Brouwer MC, van de Beek D, Heckenberg SGB, Spanjaard L, de Gans J. Community-acquired Listeria monocytogenes meningitis in adults. Clinical Infectious Diseases. 2006;43(10):1233–1238. PubMed
Dzupova O, Rozsypal H, Prochazka B, Benes J. Acute bacterial meningitis in adults: predictors of outcome. Scandinavian Journal of Infectious Diseases. 2009;41(5):348–354. PubMed
Mylonakis E, Hohmann EL, Calderwood SB. Central nervous system infection with Listeria monocytogenes: 33 years’ experience at a general hospital and review of 776 episodes from the literature. Medicine. 1998;77(5):313–336. PubMed
Siegman-Igra Y, Levin R, Weinberger M, et al. Listeria monocytogenes infection in Israel and review of cases worldwide. Emerging Infectious Diseases. 2002;8(3):305–310. PubMed PMC
van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. The New England Journal of Medicine. 2004;351(18):1849–1923. PubMed
Teasdale GM, Pettigrew LEL, Wilson JTL, Murray G, Jennett B. Analyzing outcome of treatment of severe head injury: a review and update on advancing the use of the Glasgow Outcome Scale. Journal of Neurotrauma. 1998;15(8):587–597. PubMed
National Institute of Public Health, Czech Republic. Infectious diseases report database. http://www.szu.cz/tema/prevence/infekcni-nemoci.
Fernández Guerrero ML, Torres R, Mancebo B, et al. Antimicrobial treatment of invasive non-perinatal human listeriosis and the impact of the underlying disease on prognosis. Clinical Microbiology and Infection. 2012;18(7):690–695. PubMed
Gerner-Smidt P, Ethelberg S, Schiellerup P, et al. Invasive listeriosis in Denmark 1994–2003: a review of 299 cases with special emphasis on risk factors for mortality. Clinical Microbiology and Infection. 2005;11(8):618–624. PubMed
Goulet V, Marchetti P. Listeriosis in 225 non-pregnant patients in 1992: clinical aspects and outcome in relation to predisposing conditions. Scandinavian Journal of Infectious Diseases. 1996;28(4):367–374. PubMed
Julián A, Jiménez Á, de Górgolas M, Fernández R, Fernández ML. Infecciones por Listeria monocytogenes en el adulto. Aspectos clínicos y microbiológicos de una enfermedad cambiante. Enfermedades Infecciosas y Microbiología Clínica. 2001;19(7):297–303. PubMed
Mitjà O, Pigrau C, Ruiz I, et al. Predictors of mortality and impact of aminoglycosides on outcome in listeriosis in a retrospective cohort study. Journal of Antimicrobial Chemotherapy. 2009;64(2):416–423. PubMed
Swaminathan B, Gerner-Smidt P. The epidemiology of human listeriosis. Microbes and Infection. 2007;9(10):1236–1243. PubMed
Dzupova O, Polivkova S, Smiskova D, Benes J. Epidemiological, clinical and laboratory characteristics of bacterial meningitis in adult patients. Klinická Mikrobiologie a Infekční Lékařství. 2010;16(2):58–63. PubMed
van de Beek D, de Gans J, Tunkel AR, Wijdicks EFM. Community-acquired bacterial meningitis in adults. The New England Journal of Medicine. 2006;354(1):44–53. PubMed
Clauss HE, Lorber B. Central nervous system infection with Listeria monocytogenes . Current Infectious Disease Reports. 2008;10(4):300–306. PubMed
Lorber B. Listeriosis. Clinical Infectious Diseases. 1997;24(1):1–11. PubMed
Hof H. An update on the medical management of listeriosis. Expert Opinion on Pharmacotherapy. 2004;5(8):1727–1735. PubMed
Merle-Melet M, Dossou-Gbete L, Maurer P, et al. Is amoxicillin-cotrimoxazole the most appropriate antibiotic regimen for Listeria meningoencephalitis? Review of 22 cases and the literature. Journal of Infection. 1996;33(2):79–85. PubMed